Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S1LE
|
|||
| Former ID |
DNCL003450
|
|||
| Drug Name |
Lintuzumab Bi-213
|
|||
| Synonyms |
Bismab-A (TN)
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Discontinued in Phase 1/2 | [1] | |
| Company |
Actinium Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008571) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.